Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock - Qiagen (NYSE:QGEN)
Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics.
Source: benzinga.com
Stay updated with breaking news from Their Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics.
In this article, we will discuss the 10 best dividend stocks to buy according to Sculptor Capital.
In this article, we discuss the top 5 stock picks of Rob Cope's Columbus Point.
In this article, we discuss the 10 best stocks according to Al Gore's Generation Investment Management.
In this article, we discuss the 10 best healthcare stocks to buy.